Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer
Blake, Devon R., Vaseva, Angelina V., Hodge, Richard G., Kline, McKenzie P., Gilbert, Thomas S. K., Tyagi, Vikas, Huang, Daowei, Whiten, Gabrielle C., Larson, Jacob E., Wang, Xiaodong, Pearce, KennethVolume:
12
Language:
english
Journal:
Science Signaling
DOI:
10.1126/scisignal.aav7259
Date:
July, 2019
File:
PDF, 2.80 MB
english, 2019